SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001654954-23-002689
Filing Date
2023-03-13
Accepted
2023-03-13 09:18:26
Documents
14
Period of Report
2023-03-13
Items
Item 7.01: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 FORM 8-K edsa_8k.htm   iXBRL 8-K 23063
  Complete submission text file 0001654954-23-002689.txt   138723

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA edsa-20230313.xsd EX-101.SCH 5720
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE edsa-20230313_lab.xml EX-101.LAB 13488
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE edsa-20230313_cal.xml EX-101.CAL 898
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE edsa-20230313_pre.xml EX-101.PRE 8503
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE edsa-20230313_def.xml EX-101.DEF 2099
8 EXTRACTED XBRL INSTANCE DOCUMENT edsa_8k_htm.xml XML 3309
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37619 | Film No.: 23725943
SIC: 2834 Pharmaceutical Preparations